ABSTRACT: Primary osteoarthritis (OA) is the most common type of a joint disease. It has a polygenic risk inheritance pattern and affects older people. The etiology of this disease is not fully understood. The aim of this study was to investigate the associations between polymorphisms in pro-inflammatory interleukin-17 (IL17A and IL17F) and anti-inflammatory Toll-like Receptor 10 (TLR10) genes with the risk for development of advanced stage hip and knee primary OA in the Croatian population. A total of 500 OA patients and 597 controls were genotyped for IL17A SNP (rs2275913), IL17F SNPs (rs763780 and rs1889570), and TLR10 (rs11096957) genes. The allelic and genotypic frequencies of IL17F SNP (rs763780) showed statistically significant differences in comparisons of controls with hip-but not knee-OA patients. The major allele (T) of rs763780 was associated with the lower risk for developing hip OA (p ¼ 7.9 Â 10 À4 , OR ¼ 0.45, 95%CI ¼ 0.27-0.74), whereas the minor allele (C) was associated with susceptibility to hip OA (p ¼ 7.9 Â 10 À4 , OR¼ 2.24, 95%CI ¼ 1.35-3.72). The genotype T/T was associated with the protection to hip OA (p ¼ 3.9 Â 10 À4 , OR ¼ 0.41, 95%CI ¼ 0.24-0.70), and, lastly, the genotype T/C was associated with the higher risk to acquiring hip OA (p ¼ 2.6 Â 10 À4 , OR ¼ 2.50, 95%CI ¼ 1.47-4.25). TLR10 SNP rs11096957 was found significantly associated with predisposition to hip OA (p ¼ 0.04, OR ¼ 1.41, 95%CI ¼ 1.02-1.94) but not knee OA. Our findings suggest that hip OA in Croatian population might have a different genetic risk regarding the IL17 and TLR10 gene locus than knee OA. ß
Primary osteoarthritis (OA) is a frequent degenerative, chronic, progressive, and multifactorial joint disease with complex genetic risk. The etiology of this disease is not fully understood. The association between a genetic predisposition and risk for onset and progression of OA is complex and involves the innate and acquired immune response of the host to the biomechanical, inflammatory, immunologic, and other environmental stimuli. 1 We know that influence of pro-inflammatory and anti-inflammatory cytokines on development of OA is essential for understanding primary OA pathophysiology. One of the gene loci that could predispose to development of primary OA is located on chromosome 6 (6p12.3-q13). 2 Near this locus are genes, which encode interleukin-17A (IL-17A) and IL-17F cytokines. 3 IL-17 is a group of at least five related cytokines, among which types A and F are prominent. IL-17A/F are involved in the innate and adaptive immune responses. The disturbance in exerting their action probably contributes to pathophysiology of some autoimmune diseases and organ allograft rejection. 4 Likewise, IL-17A/F might play a role in the pathophysiology of OA. 5 Secreted primarily by activated memory CD4þ T cells of the Th17 type, which have been detected in the synovial sublining layer of patients with OA, 6 IL-17A/F binds to interleukin-17 receptor A (IL-17RA, CD217) which is expressed on many cells and tissues. 5 In patients with OA, T-cell reactivity against chondrocyte surface antigens has also been detected. 7 As pro-inflammatory cytokine, IL-17A plays an important role in tissue inflammation, especially in granulocyte mobilization (probably in concert with IL-6), 4 and IL-17F has significant role in human asthma, airway and intestinal inflammation, as well as in stimulation of cartilage matrix release and prevention of cartilage matrix synthesis. [8] [9] [10] The role of IL-17 in the pathophysiology of human OA is unclear. Evidence suggests that IL-17 is involved in the early phase of the inflammatory process and induces the release of pro-inflammatory mediators in a several cell types. 5 It has been shown that IL-17 induces IL-1b, tumor necrosis factor-a (TNF-a), and IL-6 in chondrocytes which upregulate the production of nitric oxide (NO) and matrix metalloproteinases (MMPs), as well as reduces proteoglycan levels. [11] [12] [13] In addition, in synovial fibroblasts isolated from patients with OA, IL-17 stimulates the release of vascular endothelial growth factor (VEGF).
human TLRs, TLR10 is the only member of the TLR family which has an inhibitory function (anti-inflammatory). 16 Also, it seems that the TLR-2 induced expression of collagenase contributes to the catabolism of cartilage affected by OA, suggesting that modulation of TLR expression or activation in chondrocytes can be a path that might block cartilage degradation. 17 Results of recent studies show that some TLR polymorphisms are associated with predisposition to primary knee OA (KOA) in the Chinese population. 18, 19 With all the information described above we felt prompted to analyze associations of IL-17 and TLR 10 loci in our case-control study with hip OA (HOA) and KOA patients.
Thus, the aim of the present study was to investigate the relationships between single nucleotide polymorphisms (SNP) in the following genes: IL-17A (rs2275913, G-197A), IL-17F (rs763780, T7488C; and rs1889570, 5 0 ), and TLR10 (rs11096957) and the risk for development of advanced-stage primary HOA and KOA, in the Croatian population.
PATIENTS AND METHODS
Our study is case-control study (Level 3).
Patients
In our patients, primary HOA and KOA diagnosis was made with the use of well defined clinical and radiological criteria. The clinical criteria for making HOA or KOA diagnosis were the American College of Rheumatology (ACR) guidelines for diagnosis and classification of hip OA, ACR guidelines for diagnosis and classification of KOA and Western Ontario and McMaster Universities' Osteoarthritis (WOMAC) index to assess pain, physical function and joint stiffness in patients with HOA or KOA. [20] [21] [22] Kellgren-Lawrence 23 grading scale was used for radiological assessment of OA changes in hip and knee joint. This scale is grading from 1 to 4 (4 is the worst stage) on anteroposterior and lateral joint radiographs. The inclusion criteria for participation in this case-control study was clinical and radiological diagnosis of primary HOA or KOA, indication for total knee arthroplasty (TKA), partial (unicondylar, unicompartmental) knee arthroplasty (PKA), and total hip arthroplasty (THA) according to the National Institutes of Health (NIH) Consensus Statement with obligatory signed informed consent for participating in our study. 24, 25 The exclusion criteria were primary HOA or KOA patients without indication for TKA, PKA, or THA surgery, refusal to sign informed consent for inclusion in our research, secondary form of HOA or KOA and rheumatoid arthritis (RA) of hip or knee joint.
The study included in total 500 OA patients, of which 260 HOA patients. 175 HOA patients (67.3%) were female, and 85 HOA patients (32.7%) were male. The mean age of HOA patients was 67.82 years, standard deviation (SD) ¼ 9.61, range: 31-90 years. The mean age of female HOA patients was 68.90 years, range: 46-87 years, and the mean age of male HOA patients was 65.63 years, range: 31-90 years.
The remaining 240 subjects involved in this study are KOA patients. Of them, 174 patients (72.5%) were female, and 66 patients (27.5%) were male. The mean age of KOA patients was 69.74 years, SD ¼ 7.24, range: 47-86 years. The average age of female KOA patients was 69.68 years, range:
47-86 years. The average age of male KOA patients was 69.91 years, range: 52-82 years.
The control group consisted of 597 healthy persons, of which a majority were volunteer blood donors and the rest was medical personnel at the clinical hospital centre. Females comprised 152 (25.51%), whereas 445 (74,49%) were male (mean age ¼ 42.64 years, SD ¼ 11.12, range 19-91 years). Control individuals, despite being enrolled without medical history, had neither the clinical signs of primary HOA or KOA nor any other signs of bone and joint diseases (absence of chronic pain, swelling, stiffness, poor range of motion). In our control group, we included individuals younger than 45 years of age because we would have decreased the power of the study, had we included only individuals over 45 years of age (and we would not gain much higher specificity of allele identification). Decrease in power of the study for achieving minimal increase in specificity of allele identification was also the reason to include all individuals (under and over 45 years of age) in control group in our previous studies. [26] [27] [28] [29] Radiological analysis (x-rays) of knees and hips in the control group has not been done because of ethical and financial limitations. Blood samples from control group were collected and stored at Clinical Institute for Transfusion Medicine, University Hospital Center Rijeka, Croatia after clinical evaluation, and signed informed consent to donate their blood for research purposes.
The study was approved by the Medical ethics committees of the University Hospital for Orthopaedics and Traumatology Lovran, Croatia, School of Medicine, University of Rijeka, Croatia, and Clinical Hospital Center Rijeka, Croatia.
Methods
After signing the informed consent for the participation in this study, 10 ml of peripheral venous blood was taken for research purposes from each patient with the advanced stage of primary hip or knee OA during indicated surgical procedures. Blood samples were collected in two separate 5 ml tubes with ethylenediaminetetraacetic acid (EDTA). Test tubes were encrypted with unique number for each patient and stored at À86˚C. DNAzol 1 BD Reagent (Invitrogen Corporation, Carlsbad, CA) was used for the isolation of genomic DNA from peripheral venous blood of patients and controls for the polymerase chain reaction (PCR), as described earlier. 26 PCR were conducted by the TaqMan method for all DNA samples according to manufacturer's instructions (Applied Biosystems). PCR reactions had final volume of 10 ml per one sample, 40-50 cycles of sample amplifications, and consisted of (i) 1Â MasterMix (Applied Biosystems; which contains buffer for Taq DNA Polymerase, and Taq DNA Polymerase enzyme which needs incubation on 95˚C during 10 min for activation); (ii) 5-50 ng of DNA; (iii) 0.9 mM (each) forward and reverse (specific) primer; and (iv) 0.2 mM (each) probe for every SNPs allele (oligonucleotide probe was labeled with a FAM or HEX fluorescent reporter dye at the 5 0 end and a quencher at the 3 0 end). After initial incubation at 95˚C for 10 min, each cycle includes incubation at 95˚C for 10 s followed by incubation at 60˚C for 1 min.
Genotypings were performed by the quantitative realtime Taqman PCR method for allele-specific detection using commercially available amplification kits (Life technologies, Applied Biosystems, Foster City, CA). The method employs double detection of the SNP alleles: The first is by specific IL17 AND TLR 10 GENETIC POLYMORPHISMS AND OA amplification of a DNA fragment using well-tested and carefully selected pair of primers (50-150 base pairs apart) for each SNP, and the second detection is by the hybridization of the locus-specific probes (15-20-mers) identifying each allele by virtue of being differently labeled by fluorescent dyes FAM/HEX. Fluorescence of hybridized probes was measured continuously (real-time) during 40-50 cycles of PCR by the light sensitive detection system in the Mx3005P PCR machine (Agilent, Stratagene, La Jolla, CA).
The amount of FAM/HEX fluorescent reporter dye in the sample was detected after each cycle, resulting in a fluorescence signal which is directly proportional to the amount of amplified product in the sample (i.e., number of DNA copies with specific allele). Lack of one fluorescent reporter dye in a sample is interpreted as homozygosity for another allele (because there are only two in the population).
Analysis consisted of detecting the following SNPs: IL17A rs2275913, IL17F rs763780, IL17F(5 0 ) rs1889570, TLR10 rs11096957. All polymorphisms were tested for Hardy-Weinberg equilibrium (H-W). H-W differences between cases in controls were not statistically significant.
Statistical Analysis
We used chi-square method (Statcalc program, Acastat software) for analysis of allelic and genotypic differences between patients and controls. A statistically significant difference was defined when p was <0.05. A trend to association was defined when p was higher but close to 0.05 (0.06-0.05) or when p was below 0.05, but with 95% confidence index (CI) that crossed 1.
Odds ratio (OR) in our genetic study corresponds to relative risk (the latter is calculated differently in clinical setting) for developing primary OA. If there were a statistically significant difference between patients and control group, with OR calculation we could judge possible associations with either protection or predisposition to developing OA. For example, a decreased frequency of particular allele or genotype in patients (with statistically significant difference) might imply an association with protection, and, conversely, an increased frequency might indicate an association with predisposition to the disease. OR values from 0 to 1 might indicate an association with protection to developing the disease by those that carry particular allele or genotype. In contrast, OR from 1 to 1.5 might indicate weak, from 1.5 to 2 moderate, and over 2-strong association with predisposition to developing OA.
The power of the study was calculated and predicted for all SNPs, before the start of the experiments. The power to find at least 5% difference statistically significant at p < 0.05 (a ¼ 0.05; N1 ¼ 500, N2 ¼ 597) were for the IL17F rs763780-0.85, TLR10 rs11096957-0.50, IL-17F (5 0 ) rs1889570-0.46, and IL-17A rs2275913-0.54.
RESULTS
In our case-control study (representing the Croatian Caucasian population), we compared the allelic and genotypic frequencies of four SNPs (IL17A rs2275913, IL17F rs763780, IL17F [5 0 ] rs1889570, and TLR10 rs11096957) of patients with the HOA or KOA (who underwent surgical joint replacement surgery) with healthy control group. were no statistically significant differences in HOA patients compared to controls. In Table 2 , which shows similar analysis of the allelic or genotypic IL17A SNP (rs2275913) frequencies for KOA, we found no significant differences between the KOA patients and controls. Interestingly, analysis of the IL17F SNP (rs763780) in HOA patients compared to controls showed statistically significant differences (Table 3) regarding the allele frequencies. The major allele (T) frequency difference between HOA patients compared to controls had a p value of 7.9 Â 10 À4 (OR 0.45 and 95%CI 0.27-0.74), showing that there was 55% lower risk in developing HOA in persons that carried this allele. Therefore, we suggest that this allele (T) is a marker for possible protective factor in developing HOA, in the Croatian population. The minor allele (C) frequency difference between HOA patients compared to controls had the same p value (as there are only two existing alleles in the population) À7.9 Â 10 À4 (OR 2.24 and 95%CI 1. 35-3.72 ). This OR shows that there were a 2.24 higher risk for developing HOA in persons harboring this allele. Consequently, we suggest that the minor allele (C) is a marker for possible predisposing factor in developing HOA, in the Croatian population. Furthermore, rs763780 genotypic (T/T) frequency difference in HOA patients compared to controls was significant at p ¼ 3.9 Â 10 À4 (OR 0.41 and 95%CI 0.24-0.70) ( Table 3 ). This is an indication for an association of the homozygotic T/T genotype with a protective factor that can potentially lower the risk 2.5 times in developing HOA. In the same table, heterozygotic genotypic frequency (T/C) difference between HOA and controls had a p value of 2.6 Â 10 À4 (OR 2.50 and 95%CI 1.47-4.25). This result indicated an association of heterozygotic genotype T/C with a putative risk factor that could increase the predisposition for the disease 2.5 times in the Croatian population. Table 4 shows the analysis of allelic and genotypic frequencies of IL17F SNP (rs763780) in the Croatian KOA patients. Comparison between KOA patients and the control group showed no significant differences.
Results in Table 5 illustrated allelic and genotypic frequencies of the IL17F(5 0 ) SNP (rs1889570) in the Croatian HOA patients. There were no differences between the HOA patients and controls that were statistically significant.
In Table 6 , we listed allelic and genotypic frequencies of IL17F(5 0 ) SNP (rs1889570) in the Croatian KOA patients. We have not found any statistically significant difference in comparison between the KOA patients and controls. Table 7 shows allelic and genotypic frequencies of the TLR10 SNP (rs11096957) in Croatian HOA patients and control group. The allele frequency differences of TLR10 SNP (rs11096957) were not, but genotypic frequencies were significant. However, only homozygotes' (A/A) genotypic difference had a p value of 0.04 (OR 1.41 and 95%CI 1.02-1.94), implying that 
À4
(p < 0.0008) as the major allele. However, the odds ratio equals 2.24 and 95%CI stands between 1.39 and 3.63, showing that this allele (C) might be a predisposing factor for HOA development. Genotype frequency (T/T) difference is statistically significant, and shows that T-T genotype has a potentially protective role in decreasing the risk for HOA development 2.5 times. Furthermore, genotype frequency (T/C) difference points to a possibility that T-C genotype is a predisposing factor for HOA development, which is approximately 1.5 times higher in our case-control group. there was an association with a possible predisposition factor (having over 40% higher risk for developing HOA). Furthermore, heterozygotes' (A/C) genotype difference has a p value of 0.049 (OR 0.74 and 95%CI 0.55-1.01) suggesting a trend to protection of developing HOA (with 26% lower risk). Homozygotes' (C/C) genotype difference was not statistically significant. In Table 8 allelic and genotypic frequencies of the TLR10 SNP (rs11096957) in KOA patients and control group are shown. There were no statistically significant differences between KOA patient and controls.
DISCUSSION
We investigated associations of four SNPs with the susceptibility to HOA and KOA in the Croatian population. The SNPs were distributed in the IL17A, IL17F, and TLR10 genes. Several studies by others showed that IL-17 A/F cytokines (encoded by the IL17A/IL17F genes) have pro-inflammatory role and, on the other hand, a product encoded by the TLR10 gene has an anti-inflammatory function in innate immunity. 4, 5, [8] [9] [10] 16 By studying the associations of these factors with the primary OA we intended to better understand etiopathogenesis of the disease, because the pathophysiology of IL-17 and TLR10 as relative risk for OA is unclear. Previous studies of relationships between the primary OA with IL-17A and IL-17F gene polymorphisms have shown controversial results in other populations, while the relationship of the anti-inflammatory TLR10 with the primary OA has not been explored.
IL-17 cytokine family has five known members despite having six designated ones: IL-17A, B, C, D, E, and F, 30 because IL-17E is now called IL-25. The most frequently investigated members of IL-17 family were two proteins: IL-17A and IL-17F, and both have proinflammatory activities. 4 A study by Ishigame et al. 31 showed that IL-17A has a more direct influence in driving autoimmunity when compared to IL-17F. The difference between IL-17A and IL-17F function could be explained with the increase in strength of signaling process triggered by IL-17A. IL-17A had 10-30-fold stronger downstream gene activation potential than IL-17F. 32 In RA, IL-17A and IL-17F affected the synoviocytes by stimulating similar yet different signaling pathways. Also, IL-17A regulated a larger number of genes associated with inflammatory processes than IL-17F. 33 Altogether, these data suggest that the functions of both genes are largely overlapping but different to yet unknown extent. Increased expression of IL-17A was not restricted to synovial tissues of RA patients, as it was also observed in other forms of arthritis, including primary OA. 34 It is assumed that IL-17 has a role in the etiopathogenesis of OA, however, its role has not yet been fully clarified. For example, an investigation performed by the Southam et al. 3 does not support the notion of IL17A/F as factors associated with the increased HOA susceptibility in the UK population. Genotyping of six The allelic frequency analysis of TLR10 SNP (rs11096957) showed that none of the differences between patients and controls were statistically significant. Genotypic frequency analysis of the TLR10 SNP (rs11096957) showed statistically significant differences. Homozygotes (A/A) were found in 81 HOA patients and 153 controls and this difference has a genetic polymorphisms within the IL17 locus (three IL17A SNP and three IL17F SNP) in the probands and controls showed that none were associated with primary OA. 3 On the other hand, Han et al. 35 investigated the relationship between two SNPs [IL17A G-197A (rs2275913) and IL17F T7488C (rs763780)] with the predisposition for advanced KOA in 302 patients and 300 controls in the Korean population. They found an association of IL17A G-197A (rs2275913) polymorphism with the susceptibility for primary KOA, while no association was found between IL17F T7488C (rs763780) polymorphism and KOA susceptibility. Interestingly, although the allele frequencies of IL17A G-197A (rs2275913) in the healthy Korean population were similar to the healthy Chinese and Japanese populations, 36, 37 the frequency of GA genotype was found in 53.4% and 54.8% in the Japanese and Chinese populations, 36, 37 and only 35.3% in the Korean population. 35 These differences for GA genotype frequencies show that there are ethnic variations in the frequency of this IL-17 polymorphism. 35 Given the aforementioned, and the fact that the results of the previous studies regarding the role of the IL1 gene cluster in affecting the genetic risk to OA in the Croatian population 26, 27 differ from the UK population, [38] [39] [40] [41] we conducted association analyses of the IL17A-and IL17F-locus polymorphisms for advanced HOA and KOA in the Croatian population.
Our present investigation suggests that IL17A G-197A (rs2275913) was neither associated with the susceptibility to HOA nor with the predisposition to KOA in the Croatian population. These results are in disagreement with the study by Han et al., 35 in which they found association of IL17A with KOA in the Korean population. However, in our study, allele frequencies of IL17F T7488C (rs763780) SNP showed statistically significant differences. The major allele (T) is associated with a possible protective factor while the minor allele (C) is associated with a possible predisposing factor for HOA development in the Croatian population. We believe this factor is the IL17F gene, although other neighboring genes might also be candidates, or the putative cis-acting elements in the vicinity of the tested marker (rs763780) that might act at a distance on other risk factors that are yet unknown. The reason for this conjecture is that patients with IL17F T7488C (rs763780) homozygote (T/T) genotype have 2.5 times lower risk than controls for the HOA development, and, because heterozygotes (T/C) have 1.49 times higher risk for the disease in the Croatian population. Our results with the IL17A SNP (rs2275913) are similar to the UK study, 3 but they differ with the IL17F (rs763780) regarding association analysis with HOA. There were no statistically significant differences in allelic and genotypic frequencies of IL17F SNP (rs763780) for KOA patients. Analysis of IL17F(5') SNP (rs1889570) showed lack of any association with the primary OA in Croatian HOA and KOA patients. Therefore, despite the previously reported IL17 AND TLR 10 GENETIC POLYMORPHISMS AND OA negative outcome in the analysis of the IL17A SNP in Croatian 42 and the UK 3 populations, perhaps the studies in the future should be directed towards testing the influence of IL-17F proteins in vitro or in vivo models of OA.
Association analysis of TLR10 SNP (rs11096957) with HOA in the present study showed also a statistically significant difference. Namely, homozygotes (A/A) had over 40% higher risk for HOA development. Perhaps as a support for this finding, heterozygotes (A/C) had a trend to protection (possibly reducing the risk for HOA development by 25%) in the Croatian population ( Table 7) . Analysis of TLR10 SNP (rs11096957) with KOA did not show any statistically significant difference in the present study (Table 8 ). There were no other primary OA studies to compare the association of TLR10 polymorphisms with the disease development, as ours is the first in this respect. There is, however, evidence about the possible involvement of the anti-inflammatory TLR10 in predisposing for some other complex hereditary diseases. For example, we recently reported that TLR10 (rs11096957) SNP (in particular A/A genotype) increases risk for developing pulmonary tuberculosis in the Croatian population. 43 Furthermore, another TLR10 SNP-rs4129009 (particularly AG or GG genotypes) is associated with the predisposition to developing post-bronchiolitis asthma in children from the Finnish population. 44 We wish to follow these observations and determine which risk factors are involved in the primary OA. Similarly, we would like to expand our investigation on the development of HOA and KOA in the Croatian population by correlating other inflammation-related cytokine genes' polymorphisms. An interesting and confounding aspect in the studies of susceptibility to HOA and KOA is that polymorphisms vary between different ethnic groups. 35 This could be overcome by the increase in number of participants of the casecontrol study. This would additionally allow detection of more risk factors.
All this would help in deciphering OA etiopathogenesis, which, in turn, could result with better medicaments for, perhaps, definitive treatment of OA, because current treatments can only slow down the progression and reduce symptoms of the disease.
Our case-control study has the largest number of participants among previously reported ones regarding the IL17-gene locus association with primary OA. This is the first study to investigate correlation between DNA polymorphism in vicinity of the gene encoding the anti-inflammatory TLR10 receptor protein and primary OA. In summary, our results showed an association of IL17F T7488C (rs763780) with the risk for HOA development in the Croatian population. Furthermore, there is a possible correlation between TLR10 (rs11096957) SNP and increased risk for HOA, too, however, which needs further assessment.
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